The Basic Science of Hair Biology. What Are the Causal Mechanisms for the Disordered Hair Follicle?

Dermatologic Clinics

Volumn 31, Issue 1, 2013, Pages 1-19

  Breitkopf, Trisia ^a   Leung, Gigi ^a   Yu, Mei ^a   Wang, Eddy ^a   McElwee, Kevin J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Environment; Genes; Hair disorders; Hair loss; Hormones; Inflammation

Indexed keywords

ANDROGEN; FINASTERIDE; HORMONE; MINOXIDIL;

CULTURAL ANTHROPOLOGY; DERMATOLOGIST; EMBRYO DEVELOPMENT; ENVIRONMENT; GENETICS; HAIR DISEASE; HAIR FOLLICLE; HAIR FOLLICLE DISORDER; HAIR GROWTH; HUMAN; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HAIR; HAIR DISEASES; HAIR FOLLICLE; HUMANS;

EID: 84869148733     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2012.08.006     Document Type: Review

References (160)

1. Dixson B.J., Vasey L.V. Beards augment perceptions of men's age, social status, and aggressiveness, but not attractiveness. Behav Ecol 2012, 23:481-490.
2. Blume-Peytavi U., Hillmann K., Guarrera G. Hair growth assessment techniques. Hair growth and disorders 2008, 125-158. Springer-Verlag, Berlin. U. Blume-Peytavi, A. Tosti, D.A. Whiting (Eds.).
3. Vogt A., McElwee K.J., Blume-Peytavi U. Biology of the hair follicle. Hair growth and disorders 2008, 1-22. Springer-Verlag, Berlin. U. Blume-Peytavi, A. Tosti, D.A. Whiting (Eds.).
4. Millar S.E. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002, 118:216-225.
5. Stenn K.S., Paus R. Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494.
6. Sinclair R., McElwee K.J. Hair physiology and its disorders. Drug Discov Today Dis Mech 2008, 5:e163-e171.
7. McElwee K.J., Kissling S., Wenzel E., et al. Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla. J Invest Dermatol 2003, 121:1267-1275.
8. Muller S.A. Hair neogenesis. J Invest Dermatol 1971, 56:1-9.
9. Billingham R.E. A reconsideration of the phenomenon of hair neogenesis with particular reference to the healing of cutaneous wounds in adult mammals. Hair growth and disorders 1958, 451-468. Academic Press, New York. W. Montagna, R.A. Ellis (Eds.).
10. Yu M., Finner A., Shapiro J., et al. Hair follicles and their role in skin health. Expert Rev Dermatol 2006, 1:855-871.
11. Smith N.P. Tufted folliculitis of the scalp. J R Soc Med 1978, 71:606-608.
12. Rook A. Endocrine influences on hair growth. Br Med J 1965, 1:609-614.
13. Rudolph K.L., Chang S., Lee H.W., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
14. Stenn K.S., Paus R. What controls hair follicle cycling?. Exp Dermatol 1999, 8:229-233. [discussion: 33-6].
15. Geyfman M., Andersen B. Clock genes, hair growth and aging. Aging (Albany NY) 2010, 2:122-128.
16. Hebert J.M., Rosenquist T., Gotz J., et al. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 1994, 78:1017-1025.
17. Pennycuik P.R., Raphael K.A. The angora locus (go) in the mouse: hair morphology, duration of growth cycle and site of action. Genet Res 1984, 44:283-291.
18. Millar S.E., Willert K., Salinas P.C., et al. WNT signaling in the control of hair growth and structure. Dev Biol 1999, 207:133-149.
19. Stenn K. Exogen is an active, separately controlled phase of the hair growth cycle. J Am Acad Dermatol 2005, 52:374-375.
20. Hanakawa Y., Li H., Lin C., et al. Desmogleins 1 and 3 in the companion layer anchor mouse anagen hair to the follicle. J Invest Dermatol 2004, 123:817-822.
21. Ma L., Liu J., Wu T., et al. 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation. Development 2003, 130:379-389.
22. Rebora A., Guarrera M. Kenogen. A new phase of the hair cycle?. Dermatology 2002, 205:108-110.
23. Guarrera M., Rebora A. Kenogen in female androgenetic alopecia. A longitudinal study. Dermatology 2005, 210:18-20.
24. Trueb R.M. Chemotherapy-induced alopecia. Semin Cutan Med Surg 2009, 28:11-14.
25. Messenger A.G., Slater D.N., Bleehen S.S. Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol 1986, 114:337-347.
26. Hordinsky M. Cicatricial alopecia: discoid lupus erythematosus. Dermatol Ther 2008, 21:245-248.
27. Whiting D.A. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 1993, 28:755-763.
28. Johnson E., Ebling F.J. The effect of plucking hairs during different phases of the follicular cycle. J Embryol Exp Morphol 1964, 12:465-474.
29. Shafir R., Tsur H. Local hirsutism at the periphery of burned skin. Br J Plast Surg 1979, 32:93.
30. Ravin N. New hair growth over fracture sites. N Engl J Med 1990, 323:350.
31. Solomons B. Disorders of the hair and their treatment before the 18th century. Br J Dermatol 1966, 78:113-120.
32. Schmitt A., Rochat A., Zeltner R., et al. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol 1996, 70:1912-1922.
33. Boxman I.L., Berkhout R.J., Mulder L.H., et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997, 108:712-715.
34. Boxman I.L., Hogewoning A., Mulder L.H., et al. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J Clin Microbiol 1999, 37:2270-2273.
35. Adachi A., Suzuki T., Tomita Y. Detection of human papillomavirus type 56 DNA, belonging to a mucous high-risk group, in hair follicles in the genital area of a woman no longer suffering from viral warts. Br J Dermatol 2004, 151:212-215.
36. Walsh N., Boutilier R., Glasgow D., et al. Exclusive involvement of folliculosebaceous units by herpes: a reflection of early herpes zoster. Am J Dermatopathol 2005, 27:189-194.
37. Akilov O.E., Butov Y.S., Mumcuoglu K.Y. A clinico-pathological approach to the classification of human demodicosis. J Dtsch Dermatol Ges 2005, 3:607-614.
38. Zichichi L., Asta G., Noto G. Pseudomonas aeruginosa folliculitis after shower/bath exposure. Int J Dermatol 2000, 39:270-273.
39. Tobin D.J., Gunin A., Magerl M., et al. Plasticity and cytokinetic dynamics of the hair follicle mesenchyme during the hair growth cycle: implications for growth control and hair follicle transformations. J Investig Dermatol Symp Proc 2003, 8:80-86.
40. Ito T., Meyer K.C., Ito N., et al. Immune privilege and the skin. Curr Dir Autoimmun 2008, 10:27-52.
41. Lu W., Shapiro J., Yu M., et al. Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006, 8:1-19.
42. Wang E., McElwee K.J. Etiopathogenesis of alopecia areata: why do our patients get it?. Dermatol Ther 2011, 24:337-347.
43. Ito T., Ito N., Bettermann A., et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004, 164:623-634.
44. Petukhova L., Duvic M., Hordinsky M., et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010, 466:113-117.
45. Alkhalifah A., Alsantali A., Wang E., et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010, 62:177-188. [quiz: 89-90].
46. McElwee K.J., Hoffmann R., Freyschmidt-Paul P., et al. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol 2002, 119:1426-1433.
47. Perret C., Wiesner-Menzel L., Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol 1984, 64:26-30.
48. Kang H., Wu W.Y., Lo B.K., et al. Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 2010, 130:2677-2680.
49. Botchkareva N.V., Ahluwalia G., Shander D. Apoptosis in the hair follicle. J Invest Dermatol 2006, 126:258-264.
50. Weedon D., Strutton G. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol 1981, 61:335-339.
51. Eichmuller S., van der Veen C., Moll I., et al. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998, 46:361-370.
52. McElwee K.J., Spiers E.M., Oliver R.F. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol 1996, 135:211-217.
53. McElwee K.J., Spiers E.M., Oliver R.F. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. Br J Dermatol 1999, 140:432-437.
54. McElwee K.J., Freyschmidt-Paul P., Hoffmann R., et al. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 2005, 124:947-957.
55. Alsaleh Q.A., Nanda A., Al-Hasawi F., et al. Concurrent appearance of alopecia areata in siblings. Pediatr Dermatol 1995, 12:285-286.
56. Stankler L. Synchronous alopecia areata in two siblings: a possible viral aetiology. Lancet 1979, 1:1303-1304.
57. McDonagh A.J., Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002, 27:405-409.
58. McElwee K.J., Tobin D.J., Bystryn J.C., et al. Alopecia areata: an autoimmune disease?. Exp Dermatol 1999, 8:371-379.
59. Sundberg J.P., Silva K.A., Li R., et al. Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol 2004, 123:294-297.
60. Skinner R.B., Light W.H., Bale G.F., et al. Alopecia areata and presence of cytomegalovirus DNA. JAMA 1995, 273:1419-1420.
61. McElwee K.J., Boggess D., Burgett B., et al. Murine cytomegalovirus is not associated with alopecia areata in C3H/HeJ mice. J Invest Dermatol 1998, 110:986-987.
62. Wise R.P., Kiminyo K.P., Salive M.E. Hair loss after routine immunizations. JAMA 1997, 278:1176-1178.
63. Sundberg J.P., Silva K.A., Zhang W., et al. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol 2009, 20:99-104.
64. McElwee K.J., Niiyama S., Freyschmidt-Paul P., et al. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 2003, 12:30-36.
65. McElwee K.J., Silva K., Beamer W.G., et al. Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol 2001, 10:420-429.
66. Zhang X., Yu M., Yu W., et al. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009, 129:1527-1538.
67. Ito N., Sugawara K., Bodo E., et al. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010, 130:995-1004.
68. Ito T. Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci 2010, 60:67-73.
69. McElwee K.J. Etiology of cicatricial alopecias: a basic science point of view. Dermatol Ther 2008, 21:212-220.
70. Harries M.J., Paus R. The pathogenesis of primary cicatricial alopecias. Am J Pathol 2010, 177:2152-2162.
71. Hutchens K.A., Balfour E.M., Smoller B.R. Comparison between Langerhans cell concentration in lichen planopilaris and traction alopecia with possible immunologic implications. Am J Dermatopathol 2011, 33:277-280.
72. Chiarini C., Torchia D., Bianchi B., et al. Immunopathogenesis of folliculitis decalvans: clues in early lesions. Am J Clin Pathol 2008, 130:526-534.
73. Meyer K.C., Klatte J.E., Dinh H.V., et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008, 159:1077-1085.
74. Harries M.J., Meyer K.C., Chaudhry I.H., et al. Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia?. Clin Exp Dermatol 2010, 35:637-644.
75. Shapiro J. Cicatricial alopecias. Dermatol Ther 2008, 21:211.
76. Karnik P., Tekeste Z., McCormick T.S., et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol 2009, 129:1243-1257.
77. Ross E.K., Tan E., Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol 2005, 53:1-37. [quiz: 38-40].
78. Lipsker D., Boeckler P., Cribier B. Tick-borne lymphadenopathy/dermacentor-borne necrosis erythema lymphadenopathy: an infectious cause of cicatricial alopecia. Clin Exp Dermatol 2008, 33:518-519.
79. Tosti A., Piraccini B.M., Iorizzo M., et al. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 2005, 52:55-60.
80. Kruk-Jeromin J., Janik J., Rykala J. Aplasia cutis congenita of the scalp. Report of 16 cases. Dermatol Surg 1998, 24:549-553.
81. Trakimas C., Sperling L.C., Skelton H.G., et al. Clinical and histologic findings in temporal triangular alopecia. J Am Acad Dermatol 1994, 31:205-209.
82. Chassaing N., Bourthoumieu S., Cossee M., et al. Mutations in EDAR account for one-quarter of non-ED1-related hypohidrotic ectodermal dysplasia. Hum Mutat 2006, 27:255-259.
83. Kere J., Srivastava A.K., Montonen O., et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 1996, 13:409-416.
84. MacDermot K.D., Winter R.M., Malcolm S. Gene localisation of X-linked hypohidrotic ectodermal dysplasia (C-S-T syndrome). Hum Genet 1986, 74:172-173.
85. Zlotogorski A., Panteleyev A.A., Aita V.M., et al. Clinical and molecular diagnostic criteria of congenital atrichia with papular lesions. J Invest Dermatol 2002, 118:887-890.
86. Roberts J.L., Whiting D.A., Henry D., et al. Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree. J Investig Dermatol Symp Proc 1999, 4:261-267.
87. Bondeson J., Miles A.E. The hairy family of Burma: a four generation pedigree of congenital hypertrichosis lanuginosa. J R Soc Med 1996, 89:403-408.
88. Lavker R.M., Sun T.T., Oshima H., et al. Hair follicle stem cells. J Investig Dermatol Symp Proc 2003, 8:28-38.
89. Lindner G., Botchkarev V.A., Botchkareva N.V., et al. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997, 151:1601-1617.
90. Cece R., Cazzaniga S., Morelli D., et al. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats. Lab Invest 1996, 75:601-609.
91. Roberts J.L., Fiedler V., Imperato-McGinley J., et al. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 1999, 41:555-563.
92. Kaimal S., Thappa D.M. Diet in dermatology: revisited. Indian J Dermatol Venereol Leprol 2010, 76:103-115.
93. Goldberg L.J., Lenzy Y. Nutrition and hair. Clin Dermatol 2010, 28:412-419.
94. Headington J.T. Telogen effluvium. New concepts and review. Arch Dermatol 1993, 129:356-363.
95. Ruckert R., Lindner G., Bulfone-Paus S., et al. High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 2000, 143:1036-1039.
96. Trueb R.M. Systematic approach to hair loss in women. J Dtsch Dermatol Ges 2010, 8:284-297. 98.
97. Stout A.J., Gresser I., Thompson W.D. Inhibition of wound healing in mice by local interferon alpha/beta injection. Int J Exp Pathol 1993, 74:79-85.
98. Giacomini F., Starace M., Tosti A. Short anagen syndrome. Pediatr Dermatol 2011, 28:133-134.
99. Barraud-Klenovsek M.M., Trueb R.M. Congenital hypotrichosis due to short anagen. Br J Dermatol 2000, 143:612-617.
100. Shrivastava S.B. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol 2009, 75:20-27. [quiz: 27-8].
101. Mori O., Uno H. The effect of topical minoxidil on hair follicular cycles of rats. J Dermatol 1990, 17:276-281.
102. Whiting D.A. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996, 35:899-906.
103. Gilmore S., Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J Dermatol 2010, 51:163-167.
104. Whiting D.A. Chronic telogen effluvium. Dermatol Clin 1996, 14:723-731.
105. Aoki E., Shibasaki T., Kawana S. Intermittent foot shock stress prolongs the telogen stage in the hair cycle of mice. Exp Dermatol 2003, 12:371-377.
106. Hadshiew I.M., Foitzik K., Arck P.C., et al. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004, 123:455-457.
107. Slominski A., Wortsman J., Luger T., et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000, 80:979-1020.
108. Arck P.C., Handjiski B., Hagen E., et al. Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001, 15:2536-2538.
109. Arck P.C., Handjiski B., Peters E.M., et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003, 162:803-814.
110. Imperato-McGinley J., Guerrero L., Gautier T., et al. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974, 186:1213-1215.
111. Baldari M., Guarrera M., Rebora A. Thyroid peroxidase antibodies in patients with telogen effluvium. J Eur Acad Dermatol Venereol 2010, 24:980-982.
112. Kligman A.M. Pathologic dynamics of human hair loss. I. Telogen effuvium. Arch Dermatol 1961, 83:175-198.
113. Foitzik K., Langan E.A., Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 2009, 129:1071-1087.
114. Fischer T.W., Slominski A., Tobin D.J., et al. Melatonin and the hair follicle. J Pineal Res 2008, 44:1-15.
115. Randall V.A., Ebling F.J. Seasonal changes in human hair growth. Br J Dermatol 1991, 124:146-151.
116. Hoffmann R., Happle R. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles. Arch Dermatol Res 1999, 291:100-103.
117. Kornman K.S., Loesche W.J. The subgingival microbial flora during pregnancy. J Periodontal Res 1980, 15:111-122.
118. Riecher-Rossler A., Hafner H., Stumbaum M., et al. Can estradiol modulate schizophrenic symptomatology?. Schizophr Bull 1994, 20:203-214.
119. Baum M.J., Brand T., Ooms M., et al. Immediate postnatal rise in whole body androgen content in male rats: correlation with increased testicular content and reduced body clearance of testosterone. Biol Reprod 1988, 38:980-986.
120. Ito N., Ito T., Kromminga A., et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005, 19:1332-1334.
121. Arck P.C., Slominski A., Theoharides T.C., et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006, 126:1697-1704.
122. Ebling F.J. The biology of hair. Dermatol Clin 1987, 5:467-481.
123. Randall V.A. Androgens and human hair growth. Clin Endocrinol (Oxf) 1994, 40:439-457.
124. Kaufman K.D. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin 1996, 14:697-711.
125. Hamilton J.B. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942, 71:451.
126. Hamilton J.B. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951, 53:708-728.
127. Norwood O.T. Male pattern baldness: classification and incidence. South Med J 1975, 68:1359-1365.
128. Kaufman K.D. Androgens and alopecia. Mol Cell Endocrinol 2002, 198:89-95.
129. Sawaya M.E., Price V.H. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997, 109:296-300.
130. Jackson E.A. Hair disorders. Prim Care 2000, 27:319-332.
131. Courtois M., Loussouarn G., Hourseau C., et al. Hair cycle and alopecia. Skin Pharmacol 1994, 7:84-89.
132. Van Scott E.J., Ekel T.M. Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol 1958, 31:281-287.
133. Ibrahim L., Wright E.A. A quantitative study of hair growth using mouse and rat vibrissal follicles. I. Dermal papilla volume determines hair volume. J Embryol Exp Morphol 1982, 72:209-224.
134. Bahta A.W., Farjo N., Farjo B., et al. Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. J Invest Dermatol 2008, 128:1088-1094.
135. Itami S., Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc 2005, 10:209-211.
136. Wilson J.D., Gloyna R.E. The intranuclear metabolism of testosterone in the accessory organs of reproduction. Recent Prog Horm Res 1970, 26:309-336.
137. Bayne E.K., Flanagan J., Einstein M., et al. Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp. Br J Dermatol 1999, 141:481-491.
138. Janne O.A., Palvimo J.J., Kallio P., et al. Androgen receptor and mechanism of androgen action. Ann Med 1993, 25:83-89.
139. Nyholt D.R., Gillespie N.A., Heath A.C., et al. Genetic basis of male pattern baldness. J Invest Dermatol 2003, 121:1561-1564.
140. Chumlea W.C., Rhodes T., Girman C.J., et al. Family history and risk of hair loss. Dermatology 2004, 209:33-39.
141. Kuster W., Happle R. The inheritance of common baldness: two B or not two B?. J Am Acad Dermatol 1984, 11:921-926.
142. Ellis J.A., Harrap S.B. The genetics of androgenetic alopecia. Clin Dermatol 2001, 19:149-154.
143. Schweikert H.U., Wilson J.D. Regulation of human hair growth by steroid hormones. II. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab 1974, 39:1012-1019.
144. Harris G., Azzolina B., Baginsky W., et al. Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp. Proc Natl Acad Sci U S A 1992, 89:10787-10791.
145. Jenkins E.P., Andersson S., Imperato-McGinley J., et al. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest 1992, 89:293-300.
146. Jenkins E.P., Hsieh C.L., Milatovich A., et al. Characterization and chromosomal mapping of a human steroid 5 alpha-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 1991, 11:1102-1112.
147. Thigpen A.E., Silver R.I., Guileyardo J.M., et al. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 1993, 92:903-910.
148. Ellis J.A., Stebbing M., Harrap S.B. Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 1998, 110:849-853.
149. Hibberts N.A., Howell A.E., Randall V.A. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998, 156:59-65.
150. Ellis J.A., Stebbing M., Harrap S.B. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001, 116:452-455.
151. Cobb J.E., Zaloumis S.G., Scurrah K.J., et al. Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene. Exp Dermatol 2010, 19:1026-1028.
152. Brockschmidt F.F., Hillmer A.M., Eigelshoven S., et al. Fine mapping of the human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol 2010, 162:899-903.
153. Cobb J.E., Wong N.C., Yip L.W., et al. Evidence of increased DNA methylation of the androgen receptor gene in occipital hair follicles from men with androgenetic alopecia. Br J Dermatol 2011, 165:210-213.
154. Drake L., Hordinsky M., Fiedler V., et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999, 41:550-554.
155. Buhl A.E., Waldon D.J., Miller B.F., et al. Differences in activity of minoxidil and cyclosporin A on hair growth in nude and normal mice. Comparisons of in vivo and in vitro studies. Lab Invest 1990, 62:104-107.
156. Iwabuchi T., Maruyama T., Sei Y., et al. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. J Dermatol Sci 1995, 9:64-69.
157. Sinclair R. Male pattern androgenetic alopecia. BMJ 1998, 317:865-869.
158. Otberg N., Finner A.M., Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am 2007, 36:379-398.
159. Duvic M., Lemak N.A., Valero V., et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 1996, 35:74-78.
160. Ito M., Yang Z., Andl T., et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007, 447:316-320.